Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gentile

Showing results (11-20 of 313) with videos related to

Pageof 32
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases|January 20, 2025
Refining High-Risk Multiple Myeloma: Advancements in Genomic, Clinical, and Prognostic CriteriaEnrica Antonia Martino, Giuseppe Mele, Ernesto Vigna, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysisStefano Molica, Diana Giannarelli, Luciano Levato, et al.
Cancers|August 10, 2024
Chronic Lymphocytic Leukemia: Prognostic Factors in the Era of Novel DrugsAntonio Urso, Enrica Antonia Martino, Antonio Cuneo, et al.
Leukemia & Lymphoma|November 17, 2006
Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapyVincenzo Callea, Maura Brugiatelli, Caterina Stelitano, et al.
Expert Opinion on Pharmacotherapy|May 14, 2014
Role of new drugs incorporated into consolidation and maintenance therapy in transplant-eligible multiple myeloma patientsMassimo Gentile, Ernesto Vigna, Anna G Recchia, et al.
International Journal of Medical Microbiology : IJMM|May 31, 2014
Effects of vaginal lactobacilli in Chlamydia trachomatis infectionPaola Mastromarino, Marisa Di Pietro, Giovanna Schiavoni, et al.
Journal of Immunology Research|January 21, 2016
Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated ReviewRoberta Fedele, Massimo Martino, Anna Grazia Recchia, et al.
Expert Opinion on Investigational Drugs|March 22, 2016
Sorafenib for the treatment of multiple myelomaMassimo Gentile, Massimo Martino, Anna Grazia Recchia, et al.
The Journal of General Virology|October 24, 2003
Role of sialic acid-containing molecules and the alpha4beta1 integrin receptor in the early steps of polyomavirus infectionMaddalena Caruso, Michaela Cavaldesi, Massimo Gentile, et al.
Expert Opinion on Biological Therapy|May 23, 2013
Perspectives in the treatment of multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Pageof 32

Showing results (11-20 of 313) with videos related to

Sort By:
Pageof 32
Mediterranean Journal of Hematology and Infectious Diseases|January 20, 2025
Refining High-Risk Multiple Myeloma: Advancements in Genomic, Clinical, and Prognostic CriteriaEnrica Antonia Martino, Giuseppe Mele, Ernesto Vigna, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysisStefano Molica, Diana Giannarelli, Luciano Levato, et al.
Cancers|August 10, 2024
Chronic Lymphocytic Leukemia: Prognostic Factors in the Era of Novel DrugsAntonio Urso, Enrica Antonia Martino, Antonio Cuneo, et al.
Leukemia & Lymphoma|November 17, 2006
Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapyVincenzo Callea, Maura Brugiatelli, Caterina Stelitano, et al.
Expert Opinion on Pharmacotherapy|May 14, 2014
Role of new drugs incorporated into consolidation and maintenance therapy in transplant-eligible multiple myeloma patientsMassimo Gentile, Ernesto Vigna, Anna G Recchia, et al.
International Journal of Medical Microbiology : IJMM|May 31, 2014
Effects of vaginal lactobacilli in Chlamydia trachomatis infectionPaola Mastromarino, Marisa Di Pietro, Giovanna Schiavoni, et al.
Journal of Immunology Research|January 21, 2016
Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated ReviewRoberta Fedele, Massimo Martino, Anna Grazia Recchia, et al.
Expert Opinion on Investigational Drugs|March 22, 2016
Sorafenib for the treatment of multiple myelomaMassimo Gentile, Massimo Martino, Anna Grazia Recchia, et al.
The Journal of General Virology|October 24, 2003
Role of sialic acid-containing molecules and the alpha4beta1 integrin receptor in the early steps of polyomavirus infectionMaddalena Caruso, Michaela Cavaldesi, Massimo Gentile, et al.
Expert Opinion on Biological Therapy|May 23, 2013
Perspectives in the treatment of multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Pageof 32